Induction of the human CYP1A2 enhancer by phorbol ester

被引:21
|
作者
Quattrochi, LC [1 ]
Shih, H [1 ]
Pickwell, GV [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Sect Med Toxicol, Dept Med,Hepatobiliary Ctr, Denver, CO 80262 USA
关键词
CYP1A2; HepG2; phorbol esters; TPA; AP-1;
D O I
10.1006/abbi.1997.0491
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Induction of cytochrome (CYP) P4501A2 by such polycyclic aromatic hydrocarbons as 3-methylcholanthrene (3MC) can lead to the bioactivation of carcinogenic aromatic amines and heterocyclic amines, A 3MC response element was recently identified approximately 2.2 kb upstream of the transcription start site of the human CYP1A2 gene, Sequence analysis of this enhancer identified, in addition to a binding site for the aryl hydrocarbon receptor, two other sequences, referred to as 5'AP1 and 3'AP1, each with complete homology to the phorbol 12-O-tetradecanoate 13-acetate (TPA) response element consensus sequence. Nuclear extracts from TPA-treated HepG2 cells protected both the 5'AP1 and 3'AP1 sequences against digestion with DNase I, Gel mobility shift and supershift assays revealed that TPA treatment of HepG2 results in increased binding activity of the AP-1 proteins, c-Jun, JunD, and c-Fos, to both sites, We transiently expressed, in HepG2, either a fragment containing both the 5'AP1 and 3'AP1 sites (-2.3pT81Luc) or only the 3'AP1 site (-2.2pT81Luc) cloned into a plasmid containing the luciferase gene under transcriptional control of the thymidine kinase promoter, TPA treatment of cells transfected with -2.3pT81Luc resulted in an approximately threefold induction of luciferase activity over untreated control cells, while the -2.2pT81Luc construction containing only the 3'AP1 site displayed an approximately sixfold induction, These studies suggest that the human CYP1A2 gene may be regulated by tumor promoters in addition to polycyclic aromatic hydrocarbons. (C) 1998 Academic Press.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 50 条
  • [41] CONTRIBUTION OF CYP1A1, AND CYP1A2 TO THE ACTIVATION OF HETEROCYCLIC AMINES IN MONKEYS AND HUMAN
    EDWARDS, RJ
    MURRAY, BP
    MURRAY, S
    SCHULZ, T
    NEUBERT, D
    GANT, TW
    THORGEIRSSON, SS
    BOOBIS, AR
    DAVIES, DS
    CARCINOGENESIS, 1994, 15 (05) : 829 - 836
  • [42] Transactivation of human CYP1A1 and CYP1A2 genes by nuclear receptor LXRα
    Yoshinari, Kouichi
    Araki, Kikuko
    Yamazoe, Yasushi
    DRUG METABOLISM REVIEWS, 2011, 43 : 56 - 56
  • [43] Perazine as a potent inhibitor of human CYP1A2 but not CYP3A4
    Wójcikowski, J
    Pichard-Garcia, L
    Maurel, P
    Daniel, WA
    POLISH JOURNAL OF PHARMACOLOGY, 2002, 54 (04): : 407 - 410
  • [44] A comparative sequencing of enhancer elements in the mouse Cyp1a2 gene among mouse strains
    Mikhailova, ON
    Gulyaeva, LF
    Filipenko, ML
    Kaledin, VI
    DRUG METABOLISM REVIEWS, 2004, 36 : 72 - 72
  • [45] Evaluation of the impact of CYP1A2 induction by charbroiled meal on metabolic phenotype
    George, Joseph Anumu
    Adehin, Ayorinde
    Bolaji, Oluseye O.
    CLINICAL NUTRITION ESPEN, 2018, 27 : 96 - 99
  • [46] DOSE DEPENDENT INDUCTION OF CYP1A2 ACTIVITY BY OMEPRAZOLE (ANTRA(R))
    ROST, KL
    BROSICKE, H
    SCHEFFLER, M
    ROOTS, I
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1992, 30 (11) : 542 - 543
  • [47] Inhibitory Effects of Caffeic Acid Ester Analogues on Free Radicals and Human Liver Microsome CYP1A2 Activities
    Jaikang, Churdsak
    Chaiyasut, Chaiyavat
    Narongchai, Paitoon
    Niwatananun, Kanokporn
    Narongchai, Siripun
    Kusirisin, Winthana
    MEDICINAL CHEMISTRY, 2011, 7 (02) : 99 - 105
  • [48] Development of In Vitro methods to predict induction of CYP1A2 and CYP3A4 in humans
    Grover, G. Scott
    Brayman, Timothy G.
    Voorman, Richard L.
    Ware, Joseph A.
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2007, 5 (06) : 793 - 804
  • [49] Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2-163C>A polymorphism
    Djordjevic, Natasa
    Ghotbi, Roza
    Jankovic, Slobodan
    Aklillu, Eleni
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (07) : 697 - 703
  • [50] In situ evaluation of CYP1A2, CYP2B6 and CYP3A4/5 induction in human hepatocytes with a cocktail of probe substrates
    Amunom, Immaculate
    Brawner, Sarah
    Simpson, Jennifer
    Sawi, Janet
    Campbell, Rebecca
    Neat, Jason
    Parkinson, Andrew
    DRUG METABOLISM REVIEWS, 2009, 41 : 89 - 89